KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Shares Issued (2016 - 2025)

Chemed (CHE) has 17 years of Shares Issued data on record, last reported at $4.5 million in Q2 2025.

  • For Q2 2025, Shares Issued rose 231.8% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $27.2 million, down 51.96%, while the annual FY2025 figure was $27.2 million, 51.96% down from the prior year.
  • Shares Issued reached $4.5 million in Q2 2025 per CHE's latest filing, down from $22.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $43.9 million in Q4 2023 and bottomed at $1.4 million in Q2 2024.
  • Average Shares Issued over 5 years is $14.8 million, with a median of $9.4 million recorded in 2021.
  • Peak YoY movement for Shares Issued: skyrocketed 440.76% in 2023, then plummeted 95.17% in 2024.
  • A 5-year view of Shares Issued shows it stood at $17.9 million in 2021, then skyrocketed by 55.27% to $27.8 million in 2022, then surged by 57.74% to $43.9 million in 2023, then tumbled by 84.95% to $6.6 million in 2024, then tumbled by 32.14% to $4.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $4.5 million in Q2 2025, $22.7 million in Q1 2025, and $6.6 million in Q4 2024.